Sage Bionetworks Forges Two Partnerships to Build Computational Models of Neurobiological Diseases

The firm is working with CHDI Foundation and Takeda Pharmaceutical to develop computational models that could help identify genes and biomarkers associated with Huntington's and central nervous system diseases.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.